Gene Therapy Nomenclature
-
Upload
bill-smith -
Category
Business
-
view
106 -
download
2
Transcript of Gene Therapy Nomenclature
The FDA considers that the nomenclature system for gene therapy products needs to identify the product as a vector carrying a gene to be transferred, but that the indication should not be part of the name, nor should the name incorporate the finer details of the construct. !
Gene Therapy Nomenclature Guidelines
The simpler the name the better, while avoiding the danger of over simplification. !
Elements of the Name!
FDA 15
Elements of the Name
Gene Therapy Nomenclature Guidelines
Indication of the drug’s mechanism of action or pharmacologic class.!
The vector used in transfection!
@Three elements have been identified that are important in distinguishing a gene therapy drug and conveying safety information to the user physician. These include:!
Complete identification of the genes carried by the vector if there are 1 or 2 transgenes; for vectors containing > 3 transgenes, one or two genes will be chosen to be included in the gene qualifier based on an analysis of the impact that they have on preventing product confusion or conveying safety information.!U
SAN
16
@
Additional nomenclature elements would be a fantasy syllable(s) that serves as a unique identifier for the molecular entity and a stem indicating the gene therapy class of products or the ability of the vector to replicate. !
Gene Therapy Nomenclature Guidelines Elements of the Name!
USA
N
17
USA
N
@
1st Word: Corresponds to the gene component !
Prefix: Fantasy element to provide unique identification; to contribute to the distinct name!
Infix: Element to denote the gene’s mechanism of action (pharmacologic class)!
Gene Therapy Nomenclature Guidelines
Elements of the Name!
1st
infix prefix
-cima- [cytosine deaminase] -ermin- [growth factor] -kin- [interleukins] -lim- [immunomodulator] -lip- [human lipoprotein lipase] -mul- [multiple gene]
-stim- [colony stimulating factor] -tima- [thymidine kinase] -tusu- [tumor supression]
18
USA
N
@
Stem: Element to indicate gene. -gene
2nd Word: corresponds to the vector component
Prefix: Fantasy element to provide unique identification; to contribute to the distinct name
Gene Therapy Nomenclature Guidelines
Elements of the Name
stem prefix
2nd word
19
@
-adeno- [adenovirus] -cana- [canarypox virus] -foli- [fowlpox virus] -herpa- [herpes virus] -lenti- [lentivirus] -morbilli- [paramyxoviridae morbillivirus] -parvo- [adeno-associated virus (parvovirdae dependovirus)] -retro- [other retro viruses] -vaci- [vaccinia virus]
Infix: Element to denote the type of viral vector such as:
infix
Gene Therapy Nomenclature Guidelines
Elements of the Name
20
Pharmaceutical Expertise We have 20+ years of experience in evaluating pharmaceutical names in compliance with regulatory standards and can assure complete confidence in our safety and submission strategies. We offer a range of services that ease and unburden this process for your team. .
2214
Clinical Trial Identity Programs Created
137
329
Internal Innovation Brands Created
Proprietary Brand Names Created
Generic, Non-Proprietary USAN/INN Names Created
16
our n
ames…
by th
e nu
mbe
rs
8
Brand Acumen 19 Leonard St. NY, NY 10013 Bill Smith, CEO [email protected]